Analysis and Reporting
Clean, visualized, export-ready clinical trial datasets
Company profile
Company profile
ObvioHealth is a clinical trial technology company that delivers comprehensive digital solutions for decentralized and hybrid clinical trials through its ObvioGo platform. The company serves pharmaceutical companies, biotechnology firms, contract research organizations (CROs), medical device manufacturers, and consumer health companies seeking to modernize clinical research operations. ObvioHealth's integrated platform covers the entire clinical trial lifecycle—from protocol design and participant recruitment to data capture, monitoring, and regulatory reporting. The ObvioGo platform features a no-code Study Designer that enables rapid protocol development, mobile-first eConsent with built-in eSignature capabilities, precision digital recruitment tools that can accelerate enrollment up to 4x, and comprehensive ePRO/eCOA data capture systems. The platform integrates with wearables, laboratory systems, and third-party APIs while maintaining HIPAA and GDPR compliance. Through a strategic partnership with sister company SPRIM PRO, ObvioHealth combines digital innovation with deep clinical and scientific expertise, offering services including endpoint identification, instrument validation, participant journey optimization, and regulatory guidance. The company's approach emphasizes participant-centered design, real-time data visibility, and built-in compliance to make clinical trials faster, more accessible, and more efficient for both sponsors and participants across global markets.
Company description ObvioHealth official website
Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
No clinical focus areas are currently listed.
Cloud Saas deployment with recorded integration context.
Recorded integration context: Direct-to-patient shipping systems, Laboratory systems, Third-party APIs, Wearables.
Company milestones
Novotech selected ObvioGo under multi-trial license to scale digital trial delivery; Enhanced assent and counter-signature eConsent capabilities; Built-in eSignature feature launch; Template Library feature for accelerated study start-up
Partnerships
02 · Flagship portfolio
Selected source-backed Company products and the available commercial context.
Clean, visualized, export-ready clinical trial datasets
Mobile-first eConsent with built-in compliant eSignature solution
Digital patient, caregiver, and clinician outcome capture tools
Unified hub for trial logistics, DTP shipping, and device connectivity
Next-generation platform powering the future of decentralized and hybrid clinical trials
Mobile-first participant engagement app for decentralized clinical trials
Digital recruitment platform accelerating enrollment up to 4x
No-code, drag-and-drop interface for rapid clinical trial protocol development
Centralized trial management and monitoring platform
03 · Research intelligence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Journal of clinical periodontology · Jul 1, 2025
Genomic Editing and Diabetes.Advances in experimental medicine and biology · Jan 1, 2023
Real world data on cardiometabolic diseases in U.S. adults during the SARS-CoV-2 pandemic: a decentralized registry study.Cardiovascular diabetology · Feb 14, 2022
Economic Evaluation of the PCSK9 Inhibitors in Prevention of the Cardiovascular Diseases.Current cardiology reports · May 19, 2018
Clinical validation
No linked records are currently available.
Regulatory
No linked records are currently available.
04 · Company-reported outcomes
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
Digital recruitment and prescreening acceleration
Protocol development and study design
Multi-trial digital clinical trial delivery at scale
Selected ObvioGo under multi-trial license to scale digital trial delivery
Digital clinical trial execution with deep clinical expertise and DCT capabilities
True win-win partnership with solution-based approach, learning agility, customer focus, and transparency
Conducting study halfway around the world with new DCT methodology
Fantastic platform tool to keep track of enrollment with weekly updates and visibility into site activities
05 · Leadership
Leadership profiles and professional links from the current Company record.
Dennis Joseph
Head of Clinical Development
06 · Company updates
Recent articles published on ObvioHealth's official website.
No Company updates are currently listed.
07 · HAIC coverage
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Curated official destinations from the active Company record.
09 · Market pathway
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Companies using AI to optimize clinical trial design, accelerate patient recruitment, match patients to trials, predict trial outcomes, or improve clinical research efficiency. Includes patient enrollment and screening platforms, AI-powered trial matching, and tools that reduce the time and cost of bringing new treatments to market.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market10 · Pro research
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.